Skip to main content
. 2020 Dec 16;26(2):e230–e240. doi: 10.1002/onco.13581
Name NC/NA 1 2 3 4 5 All grades
Alopecia 46% 0% 54% 0% 0% 0% 54%
Fatigue 64% 4% 25% 7% 0% 0% 36%
Nausea 81% 4% 11% 4% 0% 0% 19%
Neutrophil count decreased 83% 0% 4% 13% 0% 0% 17%
Paresthesia 78% 0% 18% 4% 0% 0% 22%
Skin and subcutaneous tissue disorders 82% 0% 18% 0% 0% 0% 18%
Constipation 85% 0% 4% 11% 0% 0% 15%
Mucositis oral 96% 0% 4% 0% 0% 0% 4%
Myalgia 96% 0% 4% 0% 0% 0% 4%
Diarrhea 96% 0% 4% 0% 0% 0% 4%
Fever 96% 0% 4% 0% 0% 0% 4%
Vomiting 93% 0% 7% 0% 0% 0% 7%
Alanine aminotransferase increased 93% 0% 7% 0% 0% 0% 7%
Nasal congestion 92% 0% 4% 4% 0% 0% 8%
Pain 96% 0% 4% 0% 0% 0% 4%
Rash acneiform 93% 0% 7% 0% 0% 0% 7%
White blood cell decreased 96% 0% 4% 0% 0% 0% 4%
Abdominal pain 100% 0% 0% 0% 0% 0% 0%
Arthralgia 96% 0% 4% 0% 0% 0% 4%
Aspartate aminotransferase increased 100% 0% 0% 0% 0% 0% 0%
Bladder infection 100% 0% 0% 0% 0% 0% 0%
Dizziness 100% 0% 0% 0% 0% 0% 0%
Edema limbs 96% 0% 4% 0% 0% 0% 4%
Headache 100% 0% 0% 0% 0% 0% 0%
Hyperglycemia 100% 0% 0% 0% 0% 0% 0%
Infections and infestations 100% 0% 0% 0% 0% 0% 0%
Insomnia 96% 0% 4% 0% 0% 0% 4%
Left ventricular systolic dysfunction 96% 0% 0% 4% 0% 0% 4%
Memory impairment 96% 0% 4% 0% 0% 0% 4%
Nail loss 96% 0% 4% 0% 0% 0% 4%
Neutropenic sepsis 100% 0% 0% 0% 0% 0% 0%
Skin infection 96% 0% 4% 0% 0% 0% 4%
Vaginal infection 100% 0% 0% 0% 0% 0% 0%
Vaginal inflammation 96% 0% 4% 0% 0% 0% 4%

See also Tables 2, 3, 4 below.

Abbreviation: NC/NA, no change from baseline/no adverse event.